Back to Journals » Lung Cancer: Targets and Therapy » Volume 1 » Default

Review

Standing the test of time in Europe? Gefitinib in the treatment of non-small-cell lung cancer

       
Total article views   HTML views PDF downloads Totals
6,573 Dovepress* 6,573+ 2,468 9,041
Totals 6,573 2,468 9,041
*Since 13 May 2010
+Since July 2016

View citations on Google Scholar